Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akiko Harada

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|August 10, 2021
[Investigating the relationship between higher life functions, overall mortality, and incidence of care needs in long-term follow-up study of the local population: The Kamogawa Cohort Study]Midori Yoshioka, Akiko Harada, Eiichi Ashizawa, et al.
Cancer Medicine|December 18, 2025
The Second Mitochondria-Derived Activator of Caspases Mimetic BI 891065 in Patients With Advanced Solid Tumors: Results From Two Phase I StudiesManish R Patel, Erika P Hamilton, Ben George, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Safety, pharmacokinetics and pharmacodynamics of idarucizumab, a specific dabigatran reversal agent in healthy Japanese volunteers: a randomized studyMasahiro Yasaka, Ippei Ikushima, Akiko Harada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 19, 2025
Long-term risk of cardiovascular mortality according to age group and blood pressure categories of the latest guidelineMichihiro Satoh, Takayoshi Ohkubo, Katsuyuki Miura, et al.
Cancer Science|October 17, 2015
Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with acute myeloid leukemiaYukio Kobayashi, Takahiro Yamauchi, Hitoshi Kiyoi, et al.
The Journal of Medical Investigation : JMI|March 6, 2009
Awa (Tokushima) lactate-fermented tea as well as green tea enhance the effect of diet restriction on obesity in ratsMisako Sogawa, Takahiro Seura, Shohei Kohno, et al.
British Journal of Clinical Pharmacology|February 24, 2017
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studiesStephen Norris, Steven Ramael, Ippei Ikushima, et al.
Thrombosis and Haemostasis|December 2, 2016
Idarucizumab does not have procoagulant effects: Assessment of thrombosis biomarkers in healthy volunteersMichael Schmohl, Stephan Glund, Akiko Harada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 22, 2023
High blood pressure and colorectal cancer mortality in a 29-year follow-up of the Japanese general population: NIPPON DATA80Takashi Hisamatsu, Aya Kadota, Takehito Hayakawa, et al.
Journal of Hypertension|June 28, 2022
Association of ambulatory blood pressure with aortic valve and coronary artery calcificationYuichi Sawayama, Takashi Hisamatsu, Aya Kadota, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|August 10, 2021
[Investigating the relationship between higher life functions, overall mortality, and incidence of care needs in long-term follow-up study of the local population: The Kamogawa Cohort Study]Midori Yoshioka, Akiko Harada, Eiichi Ashizawa, et al.
Cancer Medicine|December 18, 2025
The Second Mitochondria-Derived Activator of Caspases Mimetic BI 891065 in Patients With Advanced Solid Tumors: Results From Two Phase I StudiesManish R Patel, Erika P Hamilton, Ben George, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Safety, pharmacokinetics and pharmacodynamics of idarucizumab, a specific dabigatran reversal agent in healthy Japanese volunteers: a randomized studyMasahiro Yasaka, Ippei Ikushima, Akiko Harada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 19, 2025
Long-term risk of cardiovascular mortality according to age group and blood pressure categories of the latest guidelineMichihiro Satoh, Takayoshi Ohkubo, Katsuyuki Miura, et al.
Cancer Science|October 17, 2015
Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with acute myeloid leukemiaYukio Kobayashi, Takahiro Yamauchi, Hitoshi Kiyoi, et al.
The Journal of Medical Investigation : JMI|March 6, 2009
Awa (Tokushima) lactate-fermented tea as well as green tea enhance the effect of diet restriction on obesity in ratsMisako Sogawa, Takahiro Seura, Shohei Kohno, et al.
British Journal of Clinical Pharmacology|February 24, 2017
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studiesStephen Norris, Steven Ramael, Ippei Ikushima, et al.
Thrombosis and Haemostasis|December 2, 2016
Idarucizumab does not have procoagulant effects: Assessment of thrombosis biomarkers in healthy volunteersMichael Schmohl, Stephan Glund, Akiko Harada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 22, 2023
High blood pressure and colorectal cancer mortality in a 29-year follow-up of the Japanese general population: NIPPON DATA80Takashi Hisamatsu, Aya Kadota, Takehito Hayakawa, et al.
Journal of Hypertension|June 28, 2022
Association of ambulatory blood pressure with aortic valve and coronary artery calcificationYuichi Sawayama, Takashi Hisamatsu, Aya Kadota, et al.
Pageof 10